Takeda Pharmaceutical (TAK) Long-Term Debt Issuances (2018 - 2025)
Historic Long-Term Debt Issuances for Takeda Pharmaceutical (TAK) over the last 5 years, with Q3 2025 value amounting to $2.3 billion.
- Takeda Pharmaceutical's Long-Term Debt Issuances fell 2728.14% to $2.3 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $3.6 billion, marking a year-over-year decrease of 4653.69%. This contributed to the annual value of $6.7 billion for FY2025, which is 86990.3% up from last year.
- Takeda Pharmaceutical's Long-Term Debt Issuances amounted to $2.3 billion in Q3 2025, which was down 2728.14% from $1.3 billion recorded in Q2 2025.
- Takeda Pharmaceutical's 5-year Long-Term Debt Issuances high stood at $3.3 billion for Q2 2024, and its period low was $263.1 million during Q4 2024.
- In the last 3 years, Takeda Pharmaceutical's Long-Term Debt Issuances had a median value of $1.8 billion in 2025 and averaged $1.8 billion.
- In the last 5 years, Takeda Pharmaceutical's Long-Term Debt Issuances skyrocketed by 34690.29% in 2024 and then crashed by 6109.9% in 2025.
- Quarter analysis of 3 years shows Takeda Pharmaceutical's Long-Term Debt Issuances stood at $729.7 million in 2023, then tumbled by 63.94% to $263.1 million in 2024, then soared by 783.5% to $2.3 billion in 2025.
- Its last three reported values are $2.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $263.1 million during Q4 2024.